BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12404586)

  • 1. Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening.
    Hindmarch I; Patat A; Stanley N; Paty I; Rigney U
    Hum Psychopharmacol; 2001 Mar; 16(2):159-167. PubMed ID: 12404586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.
    Patat A; Paty I; Hindmarch I
    Hum Psychopharmacol; 2001 Jul; 16(5):369-392. PubMed ID: 12404558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.
    Danjou P; Paty I; Fruncillo R; Worthington P; Unruh M; Cevallos W; Martin P
    Br J Clin Pharmacol; 1999 Sep; 48(3):367-74. PubMed ID: 10510148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
    Blin O; Micallef J; Audebert C; Legangneux E
    J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH; Burke PJ
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
    J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
    Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
    Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of zolpidem and temazepam in transient insomnia.
    Erman MK; Erwin CW; Gengo FM; Jamieson AO; Lemmi H; Mahowald MW; Regestein QR; Roth T; Roth-Schechter B; Scharf MB; Vogel GW; Walsh JK; Ware JC
    Hum Psychopharmacol; 2001 Mar; 16(2):169-176. PubMed ID: 12404587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia.
    Drake CL; Roehrs TA; Mangano RM; Roth T
    Hum Psychopharmacol; 2000 Dec; 15(8):595-604. PubMed ID: 12404612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers.
    Patat A; Perault MC; Vandel B; Danjou P; Brohier S; Zieleniuk I; Rosenzweig P
    J Psychopharmacol; 1995 Jan; 9(2):91-101. PubMed ID: 22298734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects.
    Patat A; Rosenzweig P; Enslen M; Trocherie S; Miget N; Bozon MC; Allain H; Gandon JM
    Hum Psychopharmacol; 2000 Apr; 15(3):153-170. PubMed ID: 12404329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
    Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
    J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects.
    Boyle J; Wolford D; Gargano C; McCrea J; Cummings C; Cerchio K; Lines C
    Hum Psychopharmacol; 2009 Jan; 24(1):61-71. PubMed ID: 18985628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive performance following premature awakening from zolpidem or melatonin induced daytime sleep.
    Storm WF; Eddy DR; Welch CB; Hickey PA; Fischer J; Cardenas R
    Aviat Space Environ Med; 2007 Jan; 78(1):10-20. PubMed ID: 17225476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cognitive and psychomotor effects of nisoldipine or placebo in healthy volunteers.
    Ponciano E; Robinson L; Barreto M; Cockle SM; Hindmarch I
    Hum Psychopharmacol; 2000 Mar; 15(2):137-142. PubMed ID: 12404341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
    Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.